IQVIA Pharma Deals Review of 2023

By Lucy Haggerty, Ayush Saxena & Taskin Ahmed

Pharma Deals Review: Vol 2024 Issue 3 (Table of Contents)

Published: 28 Mar-2024

DOI: 10.3833/pdr.v2024.i3.2867     ISSN: 1756-7874

Section: Opinion & Analysis



After reaching a multiyear low in 2022, deal activity in the life sciences sector continued to slow in 2023 as challenging headwinds persisted, deterring companies from signing M&A, licensing and collaborative R&D deals over the course of the year...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details